The Future of mRNA Vaccine Production Will Rely on Cold Chain Innovations, Say Experts at Samsung Biologics
MRNA vaccine production is in the midst of a revolutionary transition to large-scale adoption. As manufacturers expand their capabilities to produce mRNA vaccines efficiently and at a variety of scales,…